Post-translational modifications and protein-specific isoforms in endometriosis revealed by 2D DIGE

Andrew N. Stephens, Stephens AN, Natalie J. Hannan, Adam Rainczuk, Rainczuk A, Katie L Meehan, Katie Meehan, Chen J, Jenny Chen, Peter K. Nicholls, Luk J F Rombauts, Luk Rombauts, Peter G. Stanton, David Robertson, David M Robertson, Robertson DM, Lois A. Salamonsen
Journal of proteome research · 2010 · vol. 9(5) , pp. 2438–2449 · doi:10.1021/pr901131p · PMID:20199104 · W2067460217
Other OA: closed CC0 ⤵ 50 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

2D DIGE and mass spectrometry identified 20 differentially abundant proteins in the eutopic endometrium of endometriosis patients, revealing significant post-translational modifications and altered biological pathways.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis is a chronic disorder affecting approximately 10% of women in whom endometrial tissue forms painful lesions outside the uterus. It has a major impact on their physical, mental and social well-being but has no known cure, and there is no nonsurgical means of diagnosis. We have used a proteomic approach to identify proteins with altered abundance in the eutopic endometrium of endometriosis patients in the midsecretory phase of the menstrual cycle. 2D-differential in gel electrophoresis (DIGE) and mass spectrometry identified 20 proteins that were present at different levels in endometriosis patients (p < 0.05), many of which have not previously been associated with endometriosis. Protein abundance changes did not correlate well with published gene array data, emphasizing the extensive post-translational modification that occurs in this tissue. Abundance or localization changes in endometrial tissue were validated by immunohistochemistry and Western blotting for three proteins, vimentin (VIM), peroxiredoxin 6 (PRDX6), and ribonuclease/angiogenin inhibitor 1 (RNH1), while observed changes could not be confirmed for coronin 1A (CORO1A) or transgelin (TAGLN2). In addition, multiple charge and size isoforms were observed for PDRX6 and vimentin (VIM), and an additional PDRX6 isoform was observed in endometriosis patients that was below the level of detection in healthy women. Biological pathway analysis identified that cytoskeletal remodeling via keratin intermediate filaments, processing of the cystic fibrosis transmembrane receptor (CFTR), the glucocorticoid receptor subunit alpha (GCR), and heat shock factor 1 (HSF1) were all significantly over-represented features in endometriosis patients. This study highlights the highly dynamic nature of endometrial tissue and suggests that considerable post-translational modification of proteins is a key factor in the pathology of endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Electrophoresis, Gel, Two-Dimensional Endometriosis Protein Processing, Post-Translational Protein Processing, Post-Translational Proteome Blotting, Western Blotting, Western Carrier Proteins Carrier Proteins Carrier Proteins Cluster Analysis Cluster Analysis Databases, Genetic Databases, Genetic Electrophoresis, Gel, Two-Dimensional Electrophoresis, Gel, Two-Dimensional Endometriosis Endometriosis Female Female

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (72)

Cited by (50)

Source provenance

europepmc
last seen: 2026-10-10T06:11:15.153948+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:07:19.155540+00:00
unpaywall
last seen: 2026-10-10T06:25:47.132674+00:00
License: CC0 · commercial use OK